Free tool
Diagnostics stocks
We cover 1 company grouped under the Diagnostics theme. The median market value in the group is $4.55M. Across the group, the median move over the past trading day is −2.52%. Price change over the past year runs from −72.5% to −72.5% across the middle 80 percent of the group, with a median of −72.5%.
Other lists in this group
SaaSAI applicationsCybersecuritySemiconductor designSemiconductor equipmentFintech softwarePayment processingEcommerce marketplacesStreaming mediaGaming softwareOncologyRare diseaseMedical devicesCell therapyDiagnosticsRegional banksAsset managementGold miningCryptocurrency and digital assetsSpecialty chemicalsAll stocks
Table
1 company of 150 matches these filters.Clear filters
| Ticker | Company | Price | 1M return | YTD return | 1Y return |
|---|---|---|---|---|---|
| BGLC | BioNexus Gene Lab Corp. | $1.55 | +13.14% | −60.66% | −72.52% |
Covers ~22,000 companies across the US, Europe and Asia-Pacific (ex mainland China, Hong Kong and India), refreshed nightly. Every listed stock opens as a full analysis for $9.90.